chemistry is a living thing. it’s constantly evolving and changing. the chemours company focuses on applying the power of chemistry to shape markets, redefine industries and change lives. chemours was created from dupont's performance chemicals businesses. we are a world leader in titanium technologies, fluoroproducts and chemical solutions. we're also a company of firsts, constantly changing the formula for what chemistry can do. consider these transformative product innovations: • ti-pure™ one coat technology and market understanding enables paint formulations that cover more, with less paint and less effort • opteon™ yf refrigerants for auto air conditioning systems have a global warming potential that is 99.9% lower than the current alternative, hfc-134a • teflon ecoelite™ finish, new to the market in 2016, is the first renewably sourced, non-fluorinated fabric treatment for durable water repellency; containing 60% renewably sourced raw material it repels water and water-based stai
Company profile
Ticker
CC, CC-MM
Exchange
Website
CEO
Mark Vergnano
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Huntsman • FMC • Ecovyst • Olin • Perimeter Solutions • GCP Applied • Innospec • Ingevity • Livent • Balchem ...
Former names
Chemours Company, LLC
SEC CIK
Corporate docs
Subsidiaries
2463297 Ontario Limited • Chemours Belgium BVBA • Chemours Deutschland GmbH • Chemours France SAS • Chemours Hong Kong Holding Limited • Chemours International Operations • Chemours Italy S.r.l. • Chemours Korea Inc. • Chemours Netherlands B.V. • Chemours NL Holding 1 B.V. ...
CC stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
9 May 24
8-K
The Chemours Company Reports First Quarter 2024 Results
30 Apr 24
10-Q
2024 Q1
Quarterly report
30 Apr 24
8-K
Departure of Directors or Certain Officers
25 Apr 24
ARS
2023 FY
Annual report to shareholders
11 Apr 24
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
8-K
Regulation FD Disclosure
28 Mar 24
8-K
Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review
27 Mar 24
8-K
The Chemours Company Reports Fourth Quarter and Full Year 2023 Results
27 Mar 24
Transcripts
CC
Earnings call transcript
2024 Q1
1 May 24
CC
Earnings call transcript
2023 Q4
28 Mar 24
CC
Earnings call transcript
2023 Q3
27 Oct 23
CC
Earnings call transcript
2023 Q2
28 Jul 23
CC
Earnings call transcript
2023 Q1
28 Apr 23
CC
Earnings call transcript
2022 Q4
10 Feb 23
CC
Earnings call transcript
2022 Q3
26 Oct 22
CC
Earnings call transcript
2022 Q2
29 Jul 22
CC
Earnings call transcript
2022 Q1
3 May 22
CC
Earnings call transcript
2021 Q4
11 Feb 22
Latest ownership filings
4
Kristine M Wellman
10 May 24
4
Alvenia Scarborough
10 May 24
4
Diane I. Picho
10 May 24
4
Joseph T. Martinko
10 May 24
4
Calderon Gerardo Familiar
10 May 24
4
Denise Dignam
10 May 24
4
Ron Christopher Charles
10 May 24
4
Matthew S Abbott
10 May 24
4
Pamela Fletcher
10 May 24
3/A
Diane I. Picho
1 Apr 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn |
Cash burn (monthly) | (no burn) | (no burn) | 12.00 mm | 28.00 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 88.45 mm | 206.38 mm | n/a | n/a |
Cash remaining | n/a | n/a | 1.36 bn | 1.24 bn | n/a | n/a |
Runway (months of cash) | n/a | n/a | 113.2 | 44.3 | n/a | n/a |
Institutional ownership, Q4 2023
53.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 366 |
Opened positions | 58 |
Closed positions | 143 |
Increased positions | 81 |
Reduced positions | 125 |
13F shares | Current |
---|---|
Total value | 2.37 tn |
Total shares | 79.40 mm |
Total puts | 652.70 k |
Total calls | 288.30 k |
Total put/call ratio | 2.3 |
Largest owners | Shares | Value |
---|---|---|
FMR | 16.44 mm | $518.63 bn |
Vanguard | 16.03 mm | $505.52 bn |
BK Bank Of New York Mellon | 5.79 mm | $182.53 bn |
Massachusetts Financial Services | 4.76 mm | $150.24 bn |
STT State Street | 4.51 mm | $142.35 bn |
Marshall Wace | 3.91 mm | $123.38 bn |
JPM JPMorgan Chase & Co. | 3.54 mm | $111.52 bn |
Dimensional Fund Advisors | 2.55 mm | $80.34 bn |
American Century Companies | 1.43 mm | $45.00 bn |
Vaughan Nelson Investment Management | 1.38 mm | $43.58 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 May 24 | Fletcher Pamela | Common Stock | Grant | Acquire A | No | No | 0 | 1,454 | 0.00 | 1,454 |
8 May 24 | Matthew S Abbott | Common Stock | Grant | Acquire A | No | No | 0 | 11,818 | 0.00 | 46,106.225 |
8 May 24 | Matthew S Abbott | Performance Stock Option Common Stock | Grant | Acquire A | No | No | 30.25 | 32,879 | 994.59 k | 32,879 |
8 May 24 | Matthew S Abbott | Stock Option Common Stock | Grant | Acquire A | No | No | 27.5 | 31,614 | 869.39 k | 31,614 |
8 May 24 | Calderon Gerardo Familiar | Common Stock | Grant | Acquire A | No | No | 0 | 5,909 | 0.00 | 23,727.885 |
8 May 24 | Calderon Gerardo Familiar | Performance Stock Option Common Stock | Grant | Acquire A | No | No | 30.25 | 16,439 | 497.28 k | 16,439 |
8 May 24 | Calderon Gerardo Familiar | Stock Option Common Stock | Grant | Acquire A | No | No | 27.5 | 15,807 | 434.69 k | 15,807 |
8 May 24 | Kristine M Wellman | Common Stock | Grant | Acquire A | No | No | 0 | 7,727 | 0.00 | 36,339.412 |
8 May 24 | Kristine M Wellman | Performance Stock Option Common Stock | Grant | Acquire A | No | No | 30.25 | 21,498 | 650.31 k | 21,498 |
8 May 24 | Kristine M Wellman | Stock Option Common Stock | Grant | Acquire A | No | No | 27.5 | 20,671 | 568.45 k | 20,671 |
News
Chemours Discontinues US Sales Of Legacy Freon Refrigerants 404A And 507
2 May 24
Chemours Expects Q2 Consolidated Net Sales To Increase Approximately 15% Sequentially
30 Apr 24
Chemours Q1 2024 Adj EPS $0.32 Beats $0.18 Estimate
30 Apr 24
Chemours Q1 Sales $1.350B Beat $1.349B Estimate
30 Apr 24
Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
16 Apr 24
Press releases
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit
10 May 24
CC LAWSUIT ALERT: Levi & Korsinsky Notifies The Chemours Company Investors of a Class Action Lawsuit and Upcoming Deadline
10 May 24
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Chemours
10 May 24
CC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
10 May 24
THE CHEMOURS COMPANY investors: Please contact the Portnoy Law Firm to recover your losses; May 13, 2024 deadline
9 May 24